BABU YARLAGADDA S has a total of 21 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are ANADYS PHARMACEUTICALS INC, NEOTHERAPEUTICS INC and AMBIT BIOSCIENCES CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | WIPO (World Intellectual Property Organization) | 7 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Sugars | |
#5 | Climate change adaptation technologies | |
#6 | Microorganisms | |
#7 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Babu Yarlagadda S | 22 |
#2 | Kotian Pravin L | 12 |
#3 | Chand Pooran | 12 |
#4 | Kumar V Satish | 12 |
#5 | Wu Minwan | 11 |
#6 | Lin Tsu-Hsing | 7 |
#7 | Ghosh Ajit K | 4 |
#8 | El-Kattan Yahya | 4 |
#9 | Bantia Shanta | 3 |
#10 | Kamath Vivekanand P | 2 |
Publication | Filing date | Title |
---|---|---|
WO2010036407A2 | Antiviral nucleoside analogs | |
US2007203241A1 | Antiviral treatments | |
US2007244193A1 | Intramuscular antiviral treatments | |
WO2006014913A2 | Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase | |
WO03100009A2 | Enhancing the efficacy of reverse transcriptase and dna polymerase inhibitors (nucleoside analogs) using pnp inhibitors and/or 2'-deoxyguanosine and/or prodrug thereof |